Evaluation of the consensus of the national asthma treatment guidelines in Taiwan

Acta Paediatrica Taiwanica

Volumn 43, Issue 3, 2002, Pages 140-143

  Wan, Kong Sang ^a   Chen, Li Hui ^a   Lin, Yung Li ^a  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Adherence rate; Asthma guidelines; Implementation; Inhaled corticosteroid; Long acting beta 2 agonists

Indexed keywords

ANTIASTHMATIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; KETOTIFEN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; STEROID; THEOPHYLLINE;

ARTICLE; ASTHMA; DOCTOR PATIENT RELATION; EVIDENCE BASED MEDICINE; GOVERNMENT; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL PRACTICE; MORBIDITY; MORTALITY; NURSING; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRESCRIPTION; PUBLICATION; QUESTIONNAIRE; TAIWAN;

ASTHMA; HUMANS; PATIENT COMPLIANCE; PRACTICE GUIDELINES; TAIWAN;

EID: 0036313930     PISSN: 16088115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Provider education to promote implementation of clinical practice guidelines
2. Presentation of new GINA guidelines for paediatrics. The global initiative of asthma
3. Consistency of care with national guidelines for children with asthma in managed care
4. Asthma prevalence, cost, and adherence with expert guidelines on the utilization of health care services and costs in a state Medicaid population
5. Control of asthma in Canada: Failure to achieve guideline targets
6. Recent advance in inhaled corticosteroid therapy
7. Proliferation and activation of bronchial epithelial cells in corticosteroid-dependent asthma
8. Novel antiinflammatory effects of the inhaled corticosteroid fluticasone propionate during myofibroblasic differentiation
9. Low dose inhaled budesonide and formoterol in mild persistent asthma: The OPTIMA randomize trial
10. Addition of anti-leukotreine agents to inhaled corticosteroids for chronic asthma (Cochrane Review)
11. Dual components of optimal asthma therapy: Scientific and clinical rationale for the use of long-acting beta-agonists with inhaled corticosteroid
12. Clinical outcome of adding long-acting beta-agonists to inhaled corticosteroids
13. Inhaled corticosteroids, combined with long-acting beta2-agonists, Improve the perception of bronchoconstriction in asthma
14. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years
15. Inhaled fluticasone proprionate for chronic asthma
16. Formoterol used as needed-clinical effectiveness